 |
|
Intravitreal Bevacizumab (Avastin) Treatment of Neovascular Glaucoma in Ocular Ischemic Syndrome
Sang Joon Lee, Jung Joo Lee, Soo Young Kim, Shin Dong Kim
Korean J Ophthalmol. 2009;23(2):132-134. Published online 2009 Jun 9 DOI: https://doi.org/10.3341/kjo.2009.23.2.132
|
|
Citations to this article as recorded by
 Optical Coherence Tomography Angiography Before and After Bevacizumab Injection in Ocular Ischemic Syndrome
Eun Young Choi, Sung Chul Lee, Min Kim
Retina.2018; 38(3): e23. CrossRef Évolution favorable d’un cas de syndrome d’ischémie oculaire chronique bilatéral traité en urgence par chirurgie de revascularisation carotidienne
M. Haouas, N. Campolmi, M. Chikh, C. Guillemot, D. Grivet, C. Michel, P. Rizzi, A. Duprey, P. Gain, G. Thuret
Journal Français d'Ophtalmologie.2015; 38(3): e43. CrossRef Clinical and histological characteristics of canine ocular gliovascular syndrome
Amy Treadwell, Carolina Naranjo, Tiffany Blocker, Mitzi Zarfoss, Richard R. Dubielzig
Veterinary Ophthalmology.2015; 18(5): 371. CrossRef Blind Runner
Laura Pelegrín, Marina Mesquida, Amanda Rey, Bernardo Sánchez-Dalmau, Larry Frohman
Survey of Ophthalmology.2012; 57(5): 486. CrossRef Adverse events associated with intraocular injections of bevacizumab in eyes with neovascular glaucoma
Tomomi Higashide, Eiji Murotani, Yoshiaki Saito, Shinji Ohkubo, Kazuhisa Sugiyama
Graefe's Archive for Clinical and Experimental Ophthalmology.2012; 250(4): 603. CrossRef Acute Visual Loss after Intravitreal Bevacizumab Injection in a Patient with Ocular Ischemic Syndrome
Jin Woo Kim, Ie Na Yoon
Journal of the Korean Ophthalmological Society.2012; 53(12): 1893. CrossRef
|